Market Closed -
Nasdaq
02:00:01 04/05/2024 am IST
|
5-day change
|
1st Jan Change
|
8.01
USD
|
-0.74%
|
|
-3.21%
|
-1.11%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
44.77
|
38.39
|
38.83
|
73.64
|
33.27
|
15.07
|
Enterprise Value (EV)
1 |
24.65
|
21.92
|
25.57
|
55.61
|
25.65
|
13.04
|
P/E ratio
|
-12.3
x
|
11.9
x
|
6.71
x
|
8.14
x
|
-7.62
x
|
-6.75
x
|
Yield
|
6.65%
|
3.11%
|
3.25%
|
1.98%
|
4.47%
|
2.47%
|
Capitalization / Revenue
|
0.26
x
|
0.24
x
|
0.26
x
|
0.46
x
|
0.24
x
|
0.11
x
|
EV / Revenue
|
0.14
x
|
0.14
x
|
0.17
x
|
0.35
x
|
0.19
x
|
0.1
x
|
EV / EBITDA
|
7.43
x
|
2.52
x
|
3.92
x
|
5.13
x
|
20.3
x
|
18.6
x
|
EV / FCF
|
217
x
|
6.09
x
|
8.38
x
|
7.23
x
|
-11.3
x
|
-5.26
x
|
FCF Yield
|
0.46%
|
16.4%
|
11.9%
|
13.8%
|
-8.84%
|
-19%
|
Price to Book
|
1.77
x
|
1.4
x
|
1.48
x
|
3.05
x
|
2.35
x
|
1.44
x
|
Nbr of stocks (in thousands)
|
2,381
|
2,386
|
2,088
|
1,922
|
1,858
|
1,860
|
Reference price
2 |
18.80
|
16.09
|
18.60
|
38.32
|
17.90
|
8.100
|
Announcement Date
|
11/03/19
|
26/03/20
|
19/03/21
|
15/03/22
|
17/03/23
|
28/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
173.6
|
157.7
|
151.4
|
159.8
|
137.2
|
132
|
EBITDA
1 |
3.318
|
8.684
|
6.521
|
10.85
|
1.262
|
0.702
|
EBIT
1 |
1.254
|
6.596
|
4.531
|
9.127
|
-0.365
|
-0.926
|
Operating Margin
|
0.72%
|
4.18%
|
2.99%
|
5.71%
|
-0.27%
|
-0.7%
|
Earnings before Tax (EBT)
1 |
0.489
|
5.736
|
5.725
|
8.892
|
-0.479
|
-1.13
|
Net income
1 |
-3.886
|
3.289
|
6.261
|
9.842
|
-4.49
|
-2.239
|
Net margin
|
-2.24%
|
2.09%
|
4.14%
|
6.16%
|
-3.27%
|
-1.7%
|
EPS
2 |
-1.530
|
1.350
|
2.770
|
4.710
|
-2.350
|
-1.200
|
Free Cash Flow
1 |
0.1138
|
3.596
|
3.051
|
7.691
|
-2.268
|
-2.482
|
FCF margin
|
0.07%
|
2.28%
|
2.02%
|
4.81%
|
-1.65%
|
-1.88%
|
FCF Conversion (EBITDA)
|
3.43%
|
41.42%
|
46.79%
|
70.91%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
109.35%
|
48.73%
|
78.15%
|
-
|
-
|
Dividend per Share
2 |
1.250
|
0.5000
|
0.6050
|
0.7600
|
0.8000
|
0.2000
|
Announcement Date
|
11/03/19
|
26/03/20
|
19/03/21
|
15/03/22
|
17/03/23
|
28/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
20.1
|
16.5
|
13.3
|
18
|
7.61
|
2.02
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
0.11
|
3.6
|
3.05
|
7.69
|
-2.27
|
-2.48
|
ROE (net income / shareholders' equity)
|
-11.9%
|
12.5%
|
23.5%
|
39.1%
|
-23.3%
|
-18.2%
|
ROA (Net income/ Total Assets)
|
1.13%
|
6.59%
|
4.42%
|
9.13%
|
-0.42%
|
-1.28%
|
Assets
1 |
-343.2
|
49.91
|
141.8
|
107.8
|
1,070
|
174.7
|
Book Value Per Share
2 |
10.60
|
11.50
|
12.50
|
12.60
|
7.630
|
5.640
|
Cash Flow per Share
2 |
9.170
|
10.40
|
10.70
|
12.50
|
7.410
|
4.160
|
Capex
1 |
2.34
|
1.22
|
0.95
|
0.65
|
1.06
|
0.75
|
Capex / Sales
|
1.35%
|
0.77%
|
0.63%
|
0.41%
|
0.77%
|
0.57%
|
Announcement Date
|
11/03/19
|
26/03/20
|
19/03/21
|
15/03/22
|
17/03/23
|
28/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -1.11% | 15.1M | | +16.16% | 8.4B | | +3.59% | 7.49B | | +11.45% | 6.63B | | -7.15% | 3.68B | | -6.11% | 3.77B | | +1.10% | 1.4B | | +15.20% | 999M | | -36.30% | 972M | | -16.77% | 858M |
Special Foods & Wellbeing Products
|